These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 1094562)
1. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens. Watermeyer GS; Mann JI; Truswell AS; Levy I S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562 [TBL] [Abstract][Full Text] [Related]
2. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia. Howard AN; Hyams DE Br Med J; 1971 Jul; 3(5765):25-7. PubMed ID: 4933388 [TBL] [Abstract][Full Text] [Related]
3. Treatment of essential hyperlipidaemia. Fredrickson DS; Levy RI Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
4. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. Stein EA; Heimann KW S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650 [TBL] [Abstract][Full Text] [Related]
5. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986 [TBL] [Abstract][Full Text] [Related]
6. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639 [No Abstract] [Full Text] [Related]
7. Effect of clofibrate and calcium in type II A hyperlipoproteinaemia. Lehtonen A; Viikari J Acta Med Scand; 1977; 202(3):179-81. PubMed ID: 333869 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of hyperlipoidaemias]. Wolfram G Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214 [No Abstract] [Full Text] [Related]
9. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA; Olsson AG; Orö L; Rössner S Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
10. The efficacy of lipid lowering drugs alone and in combination. Hansen PF Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949 [No Abstract] [Full Text] [Related]
11. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
12. A comparison of fenofibrate and clofibrate hypolipidemic effects. Daubresse JC Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771 [No Abstract] [Full Text] [Related]
13. Biliary lipid composition during treatment with different hypolipidaemic drugs. Angelin B; Einarsson K; Leijd B Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218 [TBL] [Abstract][Full Text] [Related]
14. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate. Nordoy A; Rodset JM Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488 [No Abstract] [Full Text] [Related]
15. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate). Bergqvist N Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978 [No Abstract] [Full Text] [Related]
16. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
17. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation]. Bye A; Brox D Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134 [No Abstract] [Full Text] [Related]